Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 22;15(10):2861.
doi: 10.3390/cancers15102861.

Partial Laryngectomy for pT4a Laryngeal Cancer: Outcomes and Limits in Selected Cases

Affiliations

Partial Laryngectomy for pT4a Laryngeal Cancer: Outcomes and Limits in Selected Cases

Giovanni Succo et al. Cancers (Basel). .

Abstract

A large multi-institutional case series of laryngeal cancer (LC) T4a was carried out, including 134 cases treated with open partial horizontal laryngectomies (OPHL) +/- post-operative radiation therapy (PORT). The goal was to understand better whether OPHL can be included among the viable options in selected pT4a LC patients who refuse a standard approach, represented by total laryngectomy (TL) + PORT. All 134 patients underwent OPHL type I (supraglottic), II (supracricoid), or III (supratracheal), according to the European Laryngological Society Classification. Comparing clinical and pathological stages showed pT up-staging in 105 cases (78.4%) and pN up-staging in 19 patients (11.4%). Five-year data on overall survival, disease-specific survival, disease-free survival, freedom from laryngectomy, and laryngo-esophageal dysfunction-free survival (rate of patients surviving without a local recurrence or requiring total laryngectomy and without a feeding tube or a tracheostomy) were, respectively, 82.1%, 89.8%, 75.7%, 89.7%, and 78.3%. Overall, complications were observed in 22 cases (16.4%). Sequelae were observed in 28 patients (20.9%). No patients died during the postoperative period. This large series highlights the good onco-functional results of low-volume pT4a laryngeal tumors, with minimal or absent cartilage destruction, treated with OPHLs. The level of standardization of the indication for OPHL should allow consideration of OPHL as a valid therapeutic option in cases where the patient refuses total laryngectomy or non-surgical protocols with concomitant chemo-radiotherapy.

Keywords: OPHL; T4 laryngeal cancer; laryngeal cancer; laryngeal preservation; partial laryngectomy; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Glottic squamous cell carcinoma cT3 (left vocal cord): endoscopic and radiological (MRI) picture: the tumor was likely to be sub-staged with endoscopic evaluation alone.
Figure 2
Figure 2
The radiological finding of suspected extra laryngeal extension through the cricothyroid membrane is evidenced (yellow arrow). Intraoperative evaluation (yellow arrow) confirmed the extra laryngeal spread through a vascular foramen of the cricothyroid membrane.
Figure 3
Figure 3
Overall Survival: Forrest Plot and Kaplan–Meier Estimator. Kaplan–Meier: * = p < 0.05 (LR); # = p < 0.05 (GBW).
Figure 4
Figure 4
Disease Specific Survival: Forrest Plot and Kaplan–Meier Estimator. Kaplan–Meier: ** = p < 0.01 (LR); ## = p < 0.01 (GBW). Forrest Plot: * = <0.05.
Figure 5
Figure 5
Disease-free Survival: Forrest Plot and Kaplan–Meier Estimator. Kaplan–Meier: * = p < 0.05, *** = p < 0.001 (LR); # = p < 0.05, ### = p < 0.001 (GBW). Forrest Plot: ** = <0.01.
Figure 6
Figure 6
Freedom From Laryngectomy: Forrest Plot and Kaplan–Meier Estimator. Kaplan–Meier: *** = p < 0.001 (LR); ### = p < 0.001 (GBW). Forrest Plot: *** = <0.001.
Figure 7
Figure 7
Laryngoesophageal Dysfunction Free Survival: Forrest Plot and Kaplan–Meier Estimator. Kaplan–Meier: * = p < 0.05, ** = p < 0.01 (LR); ## = p < 0.01 (GBW). Forrest Plot: * = <0.05.

References

    1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics, 2007. CA Cancer J. Clin. 2007;57:43–66. doi: 10.3322/canjclin.57.1.43. - DOI - PubMed
    1. Allegra E., Bianco M.R., Ralli M., Greco A., Angeletti D., de Vincentiis M. Role of Clinical-Demographic Data in Survival Rates of Advanced Laryngeal Cancer. Medicina. 2021;57:267. doi: 10.3390/medicina57030267. - DOI - PMC - PubMed
    1. Stanković M., Milisavljević D., Stojanov D., Zivić M., Zivaljević S., Stanković I., Petrović S. Influential factors, complications and survival rate of primary and salvage total laryngectomy for advanced laryngeal cancer. Coll. Antropol. 2012;36((Suppl. S2)):7–12. - PubMed
    1. Ang K.K. Larynx preservation clinical trial design: Summary of key recommendations of a consensus panel. Oncologist. 2010;15((Suppl. S3)):25–29. doi: 10.1634/theoncologist.2010-S3-25. - DOI - PubMed
    1. AIOM Linee Guida Tumori Delle Testa e Del Collo. Edizione. 2018. [(accessed on 1 January 2022)]. Available online: https://www.aiom.it/wp-content/uploads/2018/11/2018_LG_AIOM_TestaCollo.pdf.

LinkOut - more resources